NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)
Buyers
Value
£424,035,364
Suppliers
- Milpharm Ltd/aurobinbdo Primary
- Kent Pharma Ltd
- Fresenius Kabi Limited
- Selective Supplies Ltd.
- Novumgen Limited
- Medreich PLC
- Martindale Pharma
- Bowmed Ibisqus Limited
- Wockhardt UK Limited
- Zentiva Pharma UK Ltd
- Ipca Laboratories UK Ltd
- Roma Pharmaceuticals Limited
- Perennial Pharma Ltd
- Consilient Health Ltd
- Pfizer Ltd
- Rosemont Pharmaceuticals Limited
- GLAXOSMITHKLINE UK LIMITED
- Seacross Pharmaceuticals Ltd
- Aventis Pharma ltd t/a Sanofi
- B. BRAUN MEDICAL LIMITED
- Macleods Pharma UK Limited
- Sandoz Ltd
- Flynn Pharma Ltd
- Dr.Reddy's Laboratories (UK) Limited
- Torbay Pharmaceuticals
- Lucane Pharma
- Glenmark Pharmaceuticals Europe Limited
- Esteve Pharmaceuticals Ltd
- Healthcare Pharma Ltd
- Sun Pharma UK Ltd
- ROVI Biotech Ltd
- PARI
- CST Pharma Limited
- Teva UK Limited
- Gerot Lannach UK Ltd
- Hameln Pharma Ltd
- ALISSA HEALTHCARE RESEARCH LIMITED
- Mylan
- Flexipharm Austrading Limited
- Day Lewis Medical Ltd
- Morningside Pharmaeuticals
- Ennogen Healthcare Ltd
- Venture Healthcare Ltd
- medac Pharma LLP
- Mercury Pharmaceuticals Limited
- AGB Pharma
- Thornton and Ross Ltd
- Sobi (Swedish Orphan Biovitrum Ltd)
- Organon Pharmaceuticals UK Ltd
- Piramal Critical care Limited
- Janssen-Cilag Ltd
- Aguettant Ltd
- AMAROX LIMITED
- Colonis Pharma Ltd
- GENNISIUM PHARMA
- Neuraxpharm UK Ltd
- Desitin Pharma Ltd
- Otsuka Pharmaceuticals UK Limited
- Tillotts Pharma UK Ltd
- ABBVIE LTD
- GH Pharma Ltd
- ASPIRE PHARMA LIMITED
- Panpharma UK Limited
Classifications
- Pharmaceutical products
Tags
- award
Submission Deadline
1 year ago
Published
6 months ago
Description
Invitation to offer for NHS National Generic Pharmaceuticals - Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)
Similar Contracts
AI Bid Assistant
Our AI-powered tool to help you create winning bids is coming soon!
Timeline complete
Complete